O'Toole David D 4

What Happened
David D. O'Toole, Chief Financial Officer of AVITA Medical, reported an acquisition of 2,000 shares on 2026-05-19. The shares were purchased at $4.24 per share for a total cost of $8,480. The Form 4 lists the transaction as an open-market or private purchase (code P); purchases are often viewed by investors as more informative than routine sales.

Key Details

• Transaction date and price: 2026-05-19, 2,000 shares at $4.24 each (total $8,480).
• Transaction type: Purchase (code P) — reported as "open market or private purchase."
• Shares owned after transaction: Not specified in the provided excerpt (the full filing may show post-transaction holdings).
• Footnote: F1 — "Includes unvested RSUs" (the filing indicates some reported ownership includes unvested restricted stock units).
• Filing timeliness: Form filed 2026-05-19 (same day as the transaction), indicating a timely report.

Context
This was a straightforward stock purchase by a company executive (not an option exercise, award, or gift). The trade size is relatively small ($8.5k). For retail investors, insider purchases can signal confidence but are not proof of future performance; consider this data point alongside company fundamentals and other insider activity.